HAE - Company ID 0000313143
HAEMONETICS CORP trades as HAE and has a market capitalization of $3.42 B, making it the #1723 largest US-listed company by market value. In its fiscal 2026 annual report the company posted revenue of $1.33B, down 2.0% from the prior year and net income of $97.31M. This page tracks HAEMONETICS CORP through 1,875 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years HAEMONETICS CORP's revenue grew from $886.12M to $1.33B, a compound annual growth rate of 4.7%. Net profit margin expanded from -3.0% to 7.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Annual report | 10-K | 2026-05-20 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
Financial release and supplemental presentation accessible online
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://bofa.veracast.com/webcasts/bofa/healthcare2026/75d0U1.cfm .
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
The call can be accessed via teleconference at: Q4 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies
The largest companies sharing HAEMONETICS CORP's SEC industry classification (surgical & medical instruments & apparatus).
HAEMONETICS CORP (HAE) has a market capitalization of $3.42 B as of 2026-07-09, ranking #1723 among US-listed companies.
HAEMONETICS CORP reported revenue of $1.33B for fiscal year 2026, a decrease of 2.0% year over year.
Yes. HAEMONETICS CORP reported net income of $97.31M in its latest fiscal year.